408OA-05A

Human Fibroblast-Like Synoviocytes-Osteoarthritis: HFLS-OA, adult

• Synonyme(s) : Human fibroblast culture
• Code UNSPSC : 41106514
• Nomenclature NACRES : NA.81

Propriétés

• Source biologique: human synovial tissues (osteoarthritic)
• Niveau de qualité: 100
• Conditionnement: pkg of 500,000 cells
• Fabricant/nom de marque: Cell Applications, Inc
• Mode de croissance: Adherent
• Caryotype: 2n = 46
• Morphologie: Fibroblast-like
• Technique(s): cell culture | mammalian: suitable
• Maladie(s) pertinente(s): arthritis; coagulation disorders
• Conditions d'expédition: dry ice
• Température de stockage: −196°C

Description

Description générale

Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details.

HFLS-RA provide an excellent cellular model for studying synoviocyte physiology in relation to development and treatment of rheumatoid arthritis.

HFLS-RA have been used in numerous research studies to:

• Study signaling pathways implicated in the development of joint inflammation and rheumatoid arthritis (Abe, 2006; Akasaka, 2005; Bai, 2012; Fan, 2013; Furuhashi, 2008; Hashizume, 2008; Matsuyama, 2010; Tsuji, 1999; Yamaguch, 2012a,b; Yano, 2001)
• Evaluate possible contribution of EBV to nonresolving rheumatoid arthritis inflammation through inducing IL-6 production by synoviocytes (Chiu, 2013)
• Evaluate the anti-inflammatory and antirheumatic activity of various compounds, such as celastrol (Venkatesha, 2011; Xu, 2013), triptolide (Kong, 2013; Lin, 2013), arsenic trioxide (Mei, 2011), Wen Luo Yin (Liu, 2013), bucillamine (Tsuji, 2007), therapeutic lyposomes (Harigai, 2007; Ichihara, 2011; Matsumoto, 2013; Negishi, 2011), anti-IL-6R and anti-CD319 antibodies (Suzuki, 2010; Woo, 2013), as well as inhibitors of NF-κB (Baima, 2010; Keith, 2005), methionine aminopeptidase-2 (Bernier, 2004), Tpl2 (Hall, 2007), aryl hydrocarbon receptor (Lahoti, 2013) and p38 MAP kinase (Wada, 2005); and additionally demonstrate the beneficial anti-inflammatory effects of low level light therapy (Yamaura, 2009)
• Investigate the causes of metalloproteinases induction in patients with Lyme disease-associated arthritis (Lin, 2001)
• Develop adenovirus-based siRNA delivery system (Arts, 2003)

Additionally, together with normal HFLS, HFLS-RA were used to:

• Identify causing agents (such as uric acid crystals or platelet microparticles) and study the immunopathological mechanisms and signal transduction pathways leading to joint inflammation in rheumatoid arthritis (Chen, 2011a; Hsu, 2012; Mathieu, 2008; Tsuji, 2012), and to demonstrate the role of estrogen signaling in increasing inflammation (Galal, 2008)
• Investigate anti-inflammatory properties of herbal compound Sinomenine suggested for rheumatoid arthritis treatment (Chen, 2011b)
• Study the effects of extracellular matrix composition on cell attachment and migration relevant to T-cell function in inflamed tissues (Evanko, 2012)

In parallel with HFLS isolated from joints of patients with osteoarthritis HFLS-RA were used in a study demonstrating the involvement of capsid proteins of parvorvirus B19 in activating synoviocyte migration and induction of the inflammatory response leading to acute symmetrical polyarthropathy (Lu, 2006).

Finally, all three types of HFLS (normal, RA and OA) were used to investigate the role of human endogenous retroviruses (HERVs) in development of rheumatoid arthritis, and suggest that activated expression of different forms of HERV contribute to development of rheumatoid arthritis symptoms by different mechanisms (Freimanis, 2010).

Origine de la lignée cellulaire

Bone

Application

synoviocyte physiology in relation to development and treatment of rheumatoid arthritis, phenotype, proinflammatory mediator production, signaling pathways, interleukin production, evaluation of anti-inflammatory and antirheumatic compounds, erosive enzyme production (matrix metalloproteinases), cell proliferation and attraction

Composants

Basal Medium containing 10% FBS & 10% DMSO

Notes préparatoires

• 2nd passage, >500,000 cells in Basal Medium containing 10% FBS & 10% DMSO
• Can be cultured at least 5 doublings

Procédure de repiquage

Please refer to the HFLS-OA Culture Protocol.

Clause de non-responsabilité

Ce produit, destiné à la recherche scientifique, est soumis à une réglementation spécifique en France, y compris pour les activités d'importation et d'exportation (Article L 1211-1 alinéa 2 du Code de la Santé Publique). L'acheteur (c'est-à-dire l'utilisateur final) est tenu d'obtenir une autorisation d'importation auprès du Ministère français de la Recherche, mentionné à l'article L1245-5-1 II du Code de la Santé Publique. En commandant ce produit, vous confirmez détenir l'autorisation d'importation requise.

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable